Rachel A. Burga - Concepedia

Author

Rachel A. Burga

George Washington University ORCID

Also Known As

R A Burga, R Burga, R. Burga, R.A. Burga, Rachel A Burga, Rachel A. Burga, Rachel Burga

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

George Washington University Children's National Roger Williams Medical Center Providence College Boston University

About

Rachel A. Burga is an author at George Washington University specializing in medicine, immunotherapy, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	619
2	Engineering	5	5	385
3	Biomedical Engineering	5	5	385
4	Cell Biology	3	3	370
5	Health Sciences	1	1	144

Rachel A. Burga

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor–Modified T-cell Therapy for CEA+ Liver Metastases Steven C. Katz, Rachel A. Burga, Elise McCormack, Clinical Cancer Research	2015	371
Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T Rachel A. Burga, Mitchell Thorn, Gary R. Point, Cancer Immunology Immunotherapy Cancer ImmunosurveillanceHepatocellular CarcinomaLiver PhysiologyImmunologyMyeloid-derived Suppressor Cells	2015	212
A functional agarose-hydroxyapatite scaffold for osteochondral interface regeneration Nora T. Khanarian, Nora M. Haney, Rachel A. Burga, Biomaterials Tissue EngineeringRegenerative MedicineSynthetic Bone SubstituteEngineeringBone Repair	2012	153
Prussian blue nanoparticle-based photothermal therapy combined with checkpoint inhibition for photothermal immunotherapy of neuroblastoma Juliana Cano‐Mejia, Rachel A. Burga, Elizabeth E. Sweeney, Nanomedicine Nanotechnology Biology and Medicine NanomedicineCheckpoint InhibitionEngineeringImmunotherapyPhotodynamic Therapy	2016	144
Cord blood natural killer cells expressing a dominant negative TGF-β receptor: Implications for adoptive immunotherapy for glioblastoma Eric Yvon, Rachel A. Burga, Allison B. Powell, Cytotherapy Neuro-oncologyCell TherapyCancer ImmunosurveillanceGliomaImmunology	2017	126
Polyamines drive myeloid cell survival by buffering intracellular pH to promote immunosuppression in glioblastoma Jason Miska, Aida Rashidi, Catalina Lee-Chang, Science Advances	2021	103
Engineering the TGFβ Receptor to Enhance the Therapeutic Potential of Natural Killer Cells as an Immunotherapy for Neuroblastoma Rachel A. Burga, Eric Yvon, Elizabeth Chorvinsky, Clinical Cancer Research	2019	80
Activation of 4-1BBL+ B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastoma Catalina Lee-Chang, Jason Miska, David Hou, The Journal of Experimental Medicine	2020	64
Conjugating Prussian Blue Nanoparticles Onto antigen-specific T Cells As a Combined Nanoimmunotherapy Rachel A. Burga, Shabnum Patel, Catherine M. Bollard, Nanomedicine	2016	61
Biliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils Lauren A. Licata, Cang T. Nguyen, Rachel A. Burga, Journal of Leukocyte Biology	2013	60

Page 1